SCHEMBL5012720

SCHEMBL5012720

C[C@]1(COc2ccc(N3CCN(Cc4cc5cc(Cl)ccc5o4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 1/20 0.55
KCNH2 Q12809 5/20 0.54
CACNA1C Q13936 1/20 0.37
SCN5A Q14524 1/20 0.37
TP53 P04637 1/20 0.36
HTR1A P08908 2/20 0.35
HTR2B P41595 2/20 0.35
DRD2 P14416 1/20 0.35
ENPP2 Q13822 1/20 0.34
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
DRD4 P21917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5012721 1.00 PTGS1 (0.55) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL6010834 0.88 PTGS1 (0.52) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL5535328 0.87 PTGS1 (0.61) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL5535340 0.87 PTGS1 (0.61) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL5541282 0.87 PTGS1 (0.61) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL2091190 0.86 PTGS1 (0.57) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL2091186 0.86 PTGS1 (0.57) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL5546516 0.86 KCNH2 (0.68) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL5547591 0.86 KCNH2 (0.68) PTGS1SLC6A2SLC6A4KCNH2CACNA1C
SCHEMBL5542718 0.86 KCNH2 (0.68) PTGS1SLC6A2SLC6A4KCNH2CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed